Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.56 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3685278 | 1.00 | CASP1 (0.56) | CASP1ADRB2ADRB1ALDH1A1KMT2A | |
| SCHEMBL29572218 | 1.00 | CASP1 (0.56) | CASP1ADRB2ADRB1ALDH1A1KMT2A | |
| SCHEMBL29572016 | 1.00 | CASP1 (0.56) | CASP1ADRB2ADRB1ALDH1A1KMT2A | |
| SCHEMBL253615 | 1.00 | CASP1 (0.56) | CASP1ADRB2ADRB1ALDH1A1KMT2A | |
| SCHEMBL31506886 | 1.00 | CASP1 (0.56) | CASP1ADRB2ADRB1ALDH1A1KMT2A | |
| Methylene Chloride SCHEMBL28084097 | 0.95 | CASP1 (0.56) | CASP1ADRB2ADRB1ALDH1A1KMT2A | |
| SCHEMBL30536648 | 0.88 | CASP1 (0.52) | CASP1ADRB2ADRB1THRBNR1I2 | |
| SCHEMBL9890698 | 0.86 | CASP1 (0.44) | CASP1ALDH1A1KMT2ATHRBNR1I2 | |
| SCHEMBL27962041 | 0.86 | CYP1A2 (0.46) | CASP1ALDH1A1KMT2ACYP2D6NFKB1 | |
| SCHEMBL6487230 | 0.83 | ALDH1A1 (0.56) | CASP1ADRB2ADRB1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116655652-A | New synthesis method of clopidogrel | 宿迁盛基医药科技有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-103524528-A | Improved preparation method of II-type clopidogrel hydrogen sulfate crystal | JILIN BROADWELL PHARMACEUTICAL CO LTD | 2014-01-22 | — | — | CN | claimed |
| EP-2970112-B1 | PHENYL CARBAMATE COMPOUND AND A COMPOSITION FOR PREVENTING OR TREATING A MEMORY LOSS-RELATED DISEASE COMPRISING THE SAME | BIO PHARM SOLUTIONS CO LTD (KR) | 2025-03-12 | — | — | EP | disclosed |
| US-20250066381-A1 | ONE-POT, MULTI-COMPONENT MANUFACTURING METHOD FOR TETRAHYDROTHIENOPYRIDINE DERIVATIVES INCLUDING N-SUBSTITUTED AMINO ACIDS | MOLECULES & MATERIALS (KR) | 2025-02-27 | — | — | US | disclosed |
| US-20250002466-A1 | PROCESS FOR THE PREPARATION OF CENOBAMATE ANND INTERMEDIATES THEREOF | METROCHEM API PVT LTD | 2025-01-02 | — | — | US | disclosed |
| EP-2968210-B1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILESY | BIO PHARM SOLUTIONS CO LTD (KR) | 2024-09-11 | — | — | EP | disclosed |
| CN-118308316-A | Biocatalysis asymmetric reaction reductase and application thereof | 湖州师范学院 | 2024-07-09 | — | — | CN | disclosed |
| CN-117924313-A | Tetrahydrothienopyridine derivative and preparation method and application thereof | 仁合益康集团有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-11931332-B2 | Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2024-03-19 | — | — | US | disclosed |
| CN-112778371-B | Thienopyridine derivative and preparation method and application thereof | 华创合成制药股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| US-11834413-B2 | Antiplatelet drugs and uses thereof | SHANGHAI CUREGENE PHARMACEUTICAL CO LTD. (CN) | 2023-12-05 | — | — | US | disclosed |
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| JP-2008182984-A | METHOD FOR PRODUCING (R)-2-CHLOROMANDELIC ACID METHYL ESTER | OKAYAMA UNIV | 2008-08-14 | — | — | JP | disclosed |
| EP-1930441-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE -HYDROXYCARBOXYLIC ACID | Daiichi Fine Chemical Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1930441-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE -HYDROXYCARBOXYLIC ACID | Daiichi Fine Chemical Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007078176-A1 | THE METHOD OF MAKING OPTICALLY ACTIVE 2-CHLOROMANDELIC ACID ESTERS AND 2-CHLOROMANDELIC ACIDS BY ENZYMATIC METHOD | ENZYTECH, LTD. (KR) | 2007-07-12 | — | — | WO | disclosed |
| CN-1314906-A | Salts of paroxetine | SMITHKLINE BEECHAM PLC (GB) | 2001-09-26 | — | — | CN | disclosed |
| EP-0816316-A1 | PROCESS FOR PRODUCING 1,2-ETHANEDIOL DERIVATIVES | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1998-01-07 | — | — | EP | disclosed |
| US-5614641-A | USING A PHOSPHINO-CONTAINING RUTHENIUM COMPLEX AS CATALYST | ELF AQUITAINE (FR) | 1997-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | PCCA, HCAR1, HCAR2 | CASP1 333/4885ADRB2 4593/4885ADRB1 4142/4885 |
| US-11834413-B2 | Antiplatelet drugs and uses thereof | PFKP, GP6, PF4 | CASP1 3907/4885ADRB2 624/4885ADRB1 764/4885 |
| US-20250066381-A1 | ONE-POT, MULTI-COMPONENT MANUFACTURING METHOD FOR TETRAHYDROTHIENOPYRIDINE DERIVATIVES INCLUDING N-SUBSTITUTED AMINO ACIDS | TBXAS1, TASP1, GART | CASP1 3617/4885ADRB2 1424/4885ADRB1 1317/4885 |
| US-20250002466-A1 | PROCESS FOR THE PREPARATION OF CENOBAMATE ANND INTERMEDIATES THEREOF | TALDO1, AURKB, PGD | CASP1 1372/4885ADRB2 3203/4885ADRB1 1747/4885 |
| US-11931332-B2 | Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease | SNCA, MAPT, CHAT | CASP1 707/4885ADRB2 2293/4885ADRB1 1173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.